Alan Lotvin - 27 Dec 2021 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP&President-PharmacyServices
Signature
/s/ Alan M. Lotvin
Issuer symbol
CVS
Transactions as of
27 Dec 2021
Net transactions value
-$17,756
Form type
4
Filing time
28 Dec 2021, 16:04:30 UTC
Previous filing
29 Jun 2021
Next filing
02 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock (restricted) Tax liability $17,756 -200 -3.3% $88.78 5,827 27 Dec 2021 Direct F1
holding CVS Common Stock 61,341 27 Dec 2021 Direct
holding CVS Common Stock 492 27 Dec 2021 By Children's Trusts
holding CVS Stock Unit 29,851 27 Dec 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CVS Phantom Stock Credits 557 27 Dec 2021 Common Stock 557 $1.00 Direct F2, F3
holding CVS Stock Option 21,386 27 Dec 2021 Common Stock 21,386 $102.26 Direct F4
holding CVS Stock Option 27,395 27 Dec 2021 Common Stock 27,395 $104.82 Direct F5
holding CVS Stock Option 32,911 27 Dec 2021 Common Stock 32,911 $78.05 Direct F6
holding CVS Stock Option 22,541 27 Dec 2021 Common Stock 22,541 $62.21 Direct F7
holding CVS Stock Option 70,702 27 Dec 2021 Common Stock 70,702 $54.19 Direct F8
holding CVS Stock Option 140,797 27 Dec 2021 Common Stock 140,797 $58.34 Direct F9, F10
holding CVS Stock Option 120,940 27 Dec 2021 Common Stock 120,940 $74.30 Direct F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction represents the withholding of shares by the Issuer to satisfy FICA taxes arising from the reporting person being retirement eligible.
F2 Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F3 Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F4 Option became exercisable in four equal annual installments, commencing 4/1/2016.
F5 Option became exercisable in four equal annual installments, commencing 4/1/2017.
F6 Option became exercisable in four equal annual installments, commencing 4/3/2018.
F7 Option became exercisable in four equal annual installments, commencing 4/1/2019.
F8 Option became exercisable in four equal annual installments, commencing 4/1/2020.
F9 The number of shares subject to the option were calculated using a 30-day average price.
F10 Option became exercisable in four equal annual installments, commencing 4/1/2021.
F11 Option becomes exercisable in four equal annual installments, commencing 4/1/2022.